Resveratrol has been proposed as an anti-obesity agent that increases fatty acid oxidation through upregulation of AMPK and PGC-1α [32,33] and downregulation of peroxisome proliferator-activated receptor gamma and CCAAT-enhancer-binding protein [34]. This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.